Professor John Turnidge AO[/caption]
FIP President Paul Sinclair AM MPS (left)[/caption]
‘Health care across the world is changing very quickly. It’s being driven by innovation, and pharmacists historically have embraced innovation and technology,' he said.
‘What excites me most about our profession at the moment is that we have the chance to do more. Our scope of practice is expanding rapidly, and with that comes opportunities to help more people deliver more outcomes and improve the health system.'
[post_title] => What are pharmacists doing in other countries?
[post_excerpt] => Pharmacists present to the International Pharmaceutical Federation (FIP) on unique services in their country to improve health and safety.
[post_status] => publish
[comment_status] => open
[ping_status] => open
[post_password] =>
[post_name] => what-are-pharmacists-doing-in-other-countries
[to_ping] =>
[pinged] =>
[post_modified] => 2024-09-04 16:43:37
[post_modified_gmt] => 2024-09-04 06:43:37
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://www.australianpharmacist.com.au/?p=27474
[menu_order] => 0
[post_type] => post
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[title_attribute] => What are pharmacists doing in other countries?
[title] => What are pharmacists doing in other countries?
[href] => https://www.australianpharmacist.com.au/what-are-pharmacists-doing-in-other-countries/
[module_atts:td_module:private] => Array
(
)
[td_review:protected] => Array
(
)
[is_review:protected] =>
[post_thumb_id:protected] => 27493
[authorType] =>
)
This educational activity was managed by PSA at the request of and with funding from GSK.[/caption]
Understanding and awareness
Topline information for shingles and RSV
Critical factors for pharmacy-led vaccination [for more information please refer to the PSA's Practice Guidelines for the provision of immunisation services]28
Natasha Dean (she/her) 
AGQ 2024 Contributors
Alexandra Bradshaw BPharm (Hons), MPS
Affiliate Associate Professor Juanita Breen PhD, MSc, BPharm, MPS, GradDipCommPracPharm
Caitlin Davies BPharm, AACPA, MPS
Han-Fang Hsiao-Telford BPharm (Hons), BPharmSci, MPS
Lily Pham BPharm, MPhil, GradCertEdStud (Higher Ed), FHEA, MPS, MSHP
Alyssa Pisano BPharm (Hons)
Karla Wright BPharm (Hons), AACPA, GradDipClinPharm, MACP JP(Qual), MPS
Suggested References
To answer these questions, you may need to refer to the following references:
- Arthritis Australia – https://arthritisaustralia.com.au/
- Australasian Society of Clinical Immunology and Allergy (ASCIA) anaphylaxis resources – www.allergy.org.au/hp/anaphylaxis
- Australasian Menopause Society – www.menopause.org.au/
- Australian Commission on Safety and Quality in Health Care – www.safetyandquality.gov.au/
- Australian Immunisation Handbook – https://immunisationhandbook.health.gov.au/
- Australian Government Aged Care Quality and Safety Commission – www.agedcarequality.gov.au/
- Australian Government Australian Digital Health Agency – www.digitalhealth.gov.au/
- Australian Government Department of Health and Aged Care – www.health.gov.au/
- Australian Government My Aged Care – www.myagedcare.gov.au/
- Australian Medicines Handbook (AMH) 2024 – https://amhonline.amh.net.au/auth
- Australian Pharmaceutical Formulary and Handbook (APF) – https://apf.psa.org.au/
- Australian Pharmacist – www.australianpharmacist.com.au/
- Dementia Support Australia – www.dementia.com.au
- Don’t Rush to Crush 4th edition – https://shpa.org.au/publications-resources/drtc
- eMIMS – www.emims.com.au/Australia
- Kidney Health Australia: CKD Management in Primary Care handbook – https://kidney.org.au/health-professionals/ckd-management-handbook
- Lung Foundation Australia: The COPD-X Plan – https://copdx.org.au/
- Lung Foundation Australia – https://lungfoundation.com.au/
- MedAdvisor: Project Stop – https://projectstop.mymedadvisor.com/
- Monash Institute of Pharmaceutical Sciences: Centre for Medicine Use and Safety – www.monash.edu/mips/themes/medicine-safety
- NSW Health Safety Notices – www.health.nsw.gov.au/sabs/Pages/default.aspx
- NSW Therapeutic Advisory Group – www.nswtag.org.au/
- Pharmaceutical Benefits Scheme (PBS) – www.pbs.gov.au
- Pharmaceutical Society of Australia – www.psa.org.au/
- Sleep Health Foundation – www.sleephealthfoundation.org.au/
- The Royal Children’s Hospital Melbourne Fact Sheets – www.rch.org.au/kidsinfo/
- The Royal Children’s Hospital Melbourne Clinical Practice Guidelines – www.rch.org.au/clinicalguide/
- The Poisons Standard – www.tga.gov.au/how-we-regulate/ingredients-and-scheduling-medicines-and-chemicals/poisons-standard-and-scheduling-medicines-and-chemicals/poisons-standard-susmp
- The Royal Women’s Hospital Fact sheets – www.thewomens.org.au/health-information/fact-sheets
- The Royal Women’s Hospital Pregnancy and Breastfeeding Medicines Guide – https://thewomenspbmg.org.au/
- Therapeutic Goods Administration – www.tga.gov.au/
- Therapeutic Guidelines – www.tg.org.au/
- Therapeutic Guidelines Antibiotic prescribing in primary care – www.tg.org.au/news/antibiotic-summary-table/
- World Health Organization – www.who.int/
Disclaimer
The Pharmaceutical Society of Australia has made every effort to ensure that, at the date of publication, the document is free from errors and that advice and information drawn upon have been provided in good faith. Neither the Pharmaceutical Society of Australia nor any person or organisation associated with the preparation of this document accepts liability for any loss which a user of this document may suffer as a result of reliance on the document and in particular for:
- use of the document for a purpose for which it was not intended
- any errors or omissions in the document
- any inaccuracy in the information or data on which the document is based or which are contained in the document
- any interpretations or opinions stated in, or which may be inferred from, the document.
© Pharmaceutical Society of Australia 2024
This publication contains material that has been provided by the Pharmaceutical Society of Australia (PSA), and may contain material provided by the Commonwealth and third parties. Copyright in material provided by the Commonwealth or third parties belongs to them. PSA owns the copyright in the publication as a whole and all material in the publication that has been developed by PSA. In relation to PSA owned material, no part may be reproduced by any process except in accordance with the provisions of the Copyright Act 1968 (Cth), or the written permission of PSA. Requests and inquiries regarding permission to use PSA material should be addressed to: Pharmaceutical Society of Australia, PO Box 42, Deakin West ACT 2600. Where you would like to use material that has been provided by the Commonwealth or third parties, contact them directly.
This publication contains material that has been provided by the Pharmaceutical Society of Australia (PSA), and may contain material provided by the Commonwealth and third parties. Copyright in material provided by the Commonwealth or third parties belongs to them. PSA owns the copyright in the publication as a whole and all material in the publication that has been developed by PSA. In relation to PSA owned material, no part may be reproduced by any process except in accordance with the provisions of the Copyright Act 1968 (Cth), or the written permission of PSA. Requests and inquiries regarding permission to use PSA material should be addressed to: Pharmaceutical Society of Australia, PO Box 42, Deakin West ACT 2600. Where you would like to use material that has been provided by the Commonwealth or third parties, contact them directly.
